Treatment patterns and outcomes in patients with metastatic colorectal cancer based on analysis of a health insurance claim database

Treatment patterns and outcomes in patients with metastatic colorectal cancer based on analysis of a health insurance claim database - Treatment patterns and outcomes in patients with metastatic colorectal cancer based on analysis of a health insurance claim database

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039590

Enrollment

471230

Registered

2020-02-26

Start date

2020-01-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metastatic colorectal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Metastatic colorectal cancer 2.First-line or second-line chemotherapy was initiated between April 2008 and September 2019

Exclusion criteria

Exclusion criteria: Nothing in particular

Design outcomes

Primary

Measure	Time frame
Efficacy 1.TTF:Time to Treatment Failure 2.TFST:Time to First Subsequent Therapy 3.OS:Overall Survival 4.Tumor Maker Safety 1.Hematological Toxicities 2.non-Hematological Toxicities	—

Countries

Japan

Contacts

Public ContactKentaro Yamazaki

Shizuoka Cancer Center Division of Gastrointestinal Oncology

k.yamazaki@scchr.jp055-989-5222

Outcome results